Tunis Med. 2021 Feb;99(2):264-268.
Hemoptysis is an alarming symptom that requires immediate investigation and management. Bronchial artery embolization (BAE) is a minimally invasive procedure that has become the treatment of choice of recurrent and massive hemoptysis.
To assess the efficacy and safety of BAE for management of recurrent and/or massive hemoptysis.
A retrospective analysis was carried out of the medical records of 46 patients who were hospitalized in our department of pneumology in Mohamed Taher Maamouri hospital for hemoptysis and who underwent bronchial arteriography (BA) for the purpose of transarterial embolization.
The most frequent causes of hemoptysis included idiopathic bronchiectasis (32.6%), pulmonary tumors (26%) and tuberculosis (8.6%) Embolization was successfully performed in 97.5% of cases. Immediate cessation of haemoptysis was achieved in 95%. Recurrence of haemoptysis was noted in 12% of cases. No major complication involving the vital or the functional prognosis, related to BAE was noted. Conclusions: Our study confirms the safety and the efficacy of the BAE for management of massive and/or recurrent hemoptysis.
咯血是一种需要立即调查和处理的危急症状。支气管动脉栓塞术（BAE）是一种微创介入治疗方法，已成为复发性和大咯血的首选治疗方法。
评估支气管动脉栓塞术（BAE）治疗复发性和/或大咯血的疗效和安全性。
对在穆罕默德·塔赫·马穆里医院肺病科因咯血住院并接受支气管动脉造影（BA）进行经动脉栓塞术的 46 例患者的病历进行回顾性分析。
最常见的咯血病因包括特发性支气管扩张症（32.6%）、肺部肿瘤（26%）和肺结核（8.6%）。97.5%的病例成功进行了栓塞。95%的患者咯血立即停止。12%的患者出现咯血复发。未发生与生命或功能预后相关的与 BAE 相关的重大并发症。
本研究证实了 BAE 治疗大咯血和/或复发性咯血的安全性和有效性。
